Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-22

Clinical Trial Update: ECG-I Targeted Ablation for Persistent AF [NA]

View source ↗

Summary

This update notes the completed status of a clinical trial evaluating ECG-I targeted ablation for persistent atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Atrial Fibrillation | NA | Status: COMPLETED